c-Met as a potential therapeutic target in triple negative breast cancer-Reference-Cited by-同舟云学术

c-Met as a potential therapeutic target in triple negative breast cancer

Published:2020 Issue: Volume: Page:295-326
ISSN:
Container-title:Cancer-Leading Proteases
language:
Short-container-title:

Author:

Chaudhary Sapana Sameer,Choudhary Sameer,Rawat Sakshi,Ahir Gouri,Bilgrami Anwar L.,Ashraf Ghulam Md

Publisher

Elsevier

Reference166 articles.

1. Preclinical evaluation of SCC244 (glumetinib), a novel, potent, and highly selective inhibitor of c-Met in MET-dependent cancer models;Ai;Mol. Cancer Ther.,2018

2. MET amplification is not rare and predicts unfavorable clinical outcomes in patients with recurrent/metastatic gastric cancer after chemotherapy;An;Cancer,2014

3. Co-expression of the HGF/SF and c-met genes during early mouse embryogenesis precedes reciprocal expression in adjacent tissues during organogenesis;Andermarcher;Dev. Genet.,1996

4. Activation of Wnt/beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice;Apte;Hepatology,2006

5. Systematic screen with kinases inhibitors reveals kinases play distinct roles in growth of osteoprogenitor cells;Bao;Int. J. Clin. Exp. Pathol.,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of the Coexpression of MET and ESR Genes on Prognosticators and Clinical Outcomes of Breast Cancer: An Analysis for the METABRIC Dataset;The Breast Journal;2024-05-09

2. Lupeol synergizes with 5-fluorouracil to combat c-MET/EphA2 mediated chemoresistance in triple negative breast cancer;iScience;2023-12

3. SynDISCO: A Mechanistic Modeling-Based Framework for Predictive Prioritization of Synergistic Drug Combinations Directed at Cell Signaling Networks;2023-04-08

4. SynDISCO: A Mechanistic Modeling-Based Framework for Predictive Prioritization of Synergistic Drug Combinations Targeting Cell Signalling Networks;Methods in Molecular Biology;2023

5. Loss of Proprotein Convertase Furin in Mammary Gland Impairs proIGF1R and proIR Processing and Suppresses Tumorigenesis in Triple Negative Breast Cancer;Cancers;2020-09-20